Zobrazeno 1 - 8
of 8
pro vyhledávání: '"R Jonathan, Henderson"'
Autor:
Neal D. Shore, Christopher Michael Pieczonka, R. Jonathan Henderson, James L. Bailen, Daniel R. Saltzstein, Raoul S. Concepcion, David Gillatt, Daniel W. Chan, Douglas Campbell, Yanling Lu, Thao Ho Le, Niantao Deng, Bradley Walsh
Publikováno v:
Journal of Clinical Oncology. 40:229-229
229 Background: Clinicians want a more accurate diagnostic test to identify patients for prostate biopsy. We have previously described the development of a Luminex based test for aggressive prostate cancer (MiCheck). To facilitate widespread deployme
Autor:
Neal D, Shore, Deepak A, Kapoor, Evan R, Goldfischer, David C, Chaikin, Earl L, Walz, R Jonathan, Henderson, Richard G, Harris, Robert D, Asinof, Gary M, Kirsh
Publikováno v:
Reviews in urology. 21(2-3)
Autor:
R. Jonathan Henderson, Przemyslaw Twardowski, Stuart Atkinson, Daniel P. Petrylak, Jason Hafron, Lucio N. Gordan, E. David Crawford, Thomas E. Keane, Maha Hussain, Neal D. Shore, Deborah M. Boldt-Houle, Raoul S. Concepcion, Richard G. Harris, A. Karim Kader, Celestia S. Higano, Judd W. Moul
Publikováno v:
The Journal of urology. 203(4)
We evaluated the timeliness of androgen deprivation therapy dosing, the impact of dosing nonadherence on testosterone, and the frequency of testosterone and prostate specific antigen testing in patients with prostate cancer.We retrospectively analyze
Autor:
Jonathan David Tward, Constantine Mantz, Neal D. Shore, Paul Nguyen, Isla Garraway, Carl A Olsson, Steve Pai-hsun Lee, Arthur Hung, R Jonathan Henderson, Stanley L. Liauw, David Raben, Michael D. Fabrizio, Daniel R. Saltzstein, Paul Yonover, Hiram Alberto Gay, Daniel Joseph Albertson, Tatjana Antic, Lauren Lenz, Steven Stone, Todd Cohen
Publikováno v:
Journal of Clinical Oncology. 39:195-195
195 Background: This study evaluated the ability of the combined clinical cell-cycle risk score (CCR) to prognosticate the risk of prostate cancer metastasis in men receiving dose-escalated radiation therapy (RT) with or without androgen deprivation
Autor:
Sandra Wissmueller, Neal D. Shore, Daniel Saltzstein, Robert Borotkanics, Julie J. Ruterbusch, Thomas A. Paivanas, Raoul S. Concepcion, Christopher Michael Pieczonka, Jennifer L. Beebe-Dimmer, Arletta van Breda, Thao Ho Le, Philip Prah, Douglas Campbell, R. Jonathan Henderson, Bradley J. Walsh, Rachel A. Levin, James Bailen
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 38:683.e1-683.e10
Background Increasing numbers of patients are presenting with aggressive prostate cancer (CaP); therefore, there exists a need to optimally identify these patients pre-biopsy. Objectives To compare the accuracy of total prostate specific antigen (PSA
Autor:
David G. Wong, R. Jonathan Henderson, Sebastian Zepeda, Sebastian Sorsaburu, Lars Viktrup, Adolfo Casabé, Claus G. Roehrborn, Carsten Henneges, Luigi F. Da Pozzo
Publikováno v:
Journal of Urology. 191:727-733
Purpose Medical treatment for men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia is 5α-reductase inhibitor monotherapy or coadministration with an α-blocker. We assessed the effects of tadalafi
Autor:
R. Jonathan Henderson
Publikováno v:
Urology Practice. 4:447-447
Publikováno v:
Urology. 48:644-646
Genital presentation of filarial disease is not uncommon in endemic areas of the world. Acute, febrile illness involving the epididymis and spermatic cord (funiculoepididymitis) is one of many such presentations. With an internationally mobile societ